# A Nasal Treatment for COVID-19

> **NCT05799521** · PHASE2 · RECRUITING · sponsor: **Indiana University** · enrollment: 40 (estimated)

## Conditions studied

- COVID-19
- Healthy

## Interventions

- **DRUG:** Optate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05799521
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-27
- **Primary completion:** 2027-03-30
- **Final completion:** 2027-03-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05799521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05799521, "A Nasal Treatment for COVID-19". Retrieved via AI Analytics 2026-09-01 from https://api.ai-analytics.org/clinical/NCT05799521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*